Article Information
History
- November 29, 2023.
Article Versions
- You are currently viewing Version 1 of this article (November 29, 2023 - 09:49).
- View Version 2, the most recent version of this article.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY 4.0 International license.
Author Information
- Paula Saffie-Awad, MD1,2,3,*,
- Inas Elsayed, PhD4,*,
- Arinola O. Sanyaolu, PhD5,*,
- Peter Wild Crea, BSc6,7,
- Artur F Schumacher Schuh, MD, PhD1,8,9,
- Kristin S Levine, MS6,10,
- Dan Vitale, MS6,10,
- Mathew J Korestky, BSc6,
- Jeffrey Kim, BA6,7,
- Thiago Peixoto Leal, PhD11,
- María Teresa Periñan, PhD12,13,14,
- Sumit Dey14,
- Alastair J Noyce14,
- Armando Reyes-Palomares15,
- Noela Rodriguez-Losada, PhD16,
- Jia Nee Foo17,18,
- Wael Mohamed, MD, PhD19,
- Karl Heilbron, PhD20,
- Lucy Norcliffe-Kaufmann, PhD20,
- the 23andMe Research Team,
- Mie Rizig14,21,
- Njideka Okubadejo22,
- Mike Nalls, PhD6,7,10,
- Cornelis Blauwendraat, PhD6,7,
- Andrew Singleton, PhD6,7,
- Hampton Leonard, MS6,7,10,21,
- Mary B Makarious, BSc7,21,
- Ignacio F. Mata, PhD11,#,
- Sara Bandres-Ciga, PhD6,CA,# and
- the Global Parkinson’s Genetics Program (GP2)
- 1Programa de Pós-Graduação em Ciências Médicas, Universidade Federal do Rio Grande do Sul, Porto Alegre, Brazil
- 2Centro de Trastornos del Movimiento (CETRAM), Santiago, Chile
- 3Clínica Santa María, Santiago, Chile
- 4Faculty of Pharmacy, University of Gezira, Wadmadani, 20, Sudan
- 5Department of Anatomy, College of Medicine, University of Lagos, Nigeria
- 6Center for Alzheimer’s and Related Dementias (CARD), National Institute on Aging and National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, MD, USA, 20814
- 7Laboratory of Neurogenetics, National Institute on Aging, National Institutes of Health, Bethesda, MD, USA
- 8Serviço de Neurologia, Hospital de Clínicas de Porto Alegre, Porto Alegre, Brazil
- 9Departamento de Farmacologia, Universidade Federal do Rio Grande do Sul, Porto Alegre, Brazil
- 10Data Tecnica International LLC, Washington, DC, USA
- 11Genomic Medicine, Lerner Research Institute, Cleveland Clinic Foundation, Cleveland, OH, USA
- 12Unidad de Trastornos del Movimiento, Servicio de Neurología y Neurofisiología Clínica, Instituto de Biomedicina de Sevilla, Hospital Universitario Virgen del Rocío/CSIC/Universidad de Sevilla, Seville, Spain
- 13Centro de Investigación Biomédica en Red sobre Enfermedades Neurodegenerativas (CIBERNED), Madrid, Spain
- 14Preventive Neurology Unit, Wolfson Institute of Population Health, Queen Mary University of London, London, UK
- 15Department of Molecular Biology and Biochemistry, Faculty of Sciences, University of Málaga, Málaga, Spain
- 16Faculty of Education Sciences, University of Málaga, Málaga, Spain
- 17Lee Kong Chian School of Medicine, Nanyang Technological University Singapore, Singapore, Singapore
- 18Laboratory of Neurogenetics, Genome Institute of Singapore, A*STAR, Singapore, Singapore
- 19Neuroscience Unit, Clinical Pharmacology Dept., Menoufiia Medical School, Egypt
- 2023andMe, Inc., Sunnyvale, CA, USA
- 21Department of Neuromuscular Diseases, UCL Queen Square Institute of Neurology, London, WC1N 3BG, United Kingdom
- 22Department of Medicine, College of Medicine, University of Lagos, Nigeria
- 23German Center for Neurodegenerative Diseases (DZNE), Tübingen, Germany
- ↵CACorresponding author Sara Bandres Ciga, Center for Alzheimer’s Disease and Related Dementias (CARD), National Institute on Aging (NIA), National Institutes of Health (NIH), 9000 Rockville Pike, NIH Building T44 Bethesda, MD 20892. Email: sara.bandresciga{at}nih.gov, Phone: +1 (301) 841-5095
Posted November 29, 2023.
Evaluating the performance of polygenic risk profiling across diverse ancestry populations in Parkinson’s disease
